BR112014013878A8 - emplastro - Google Patents

emplastro

Info

Publication number
BR112014013878A8
BR112014013878A8 BR112014013878A BR112014013878A BR112014013878A8 BR 112014013878 A8 BR112014013878 A8 BR 112014013878A8 BR 112014013878 A BR112014013878 A BR 112014013878A BR 112014013878 A BR112014013878 A BR 112014013878A BR 112014013878 A8 BR112014013878 A8 BR 112014013878A8
Authority
BR
Brazil
Prior art keywords
glycol
poly
ethylene
mass
butylene glycol
Prior art date
Application number
BR112014013878A
Other languages
English (en)
Other versions
BR112014013878A2 (pt
BR112014013878B1 (pt
Inventor
Kijima Masaru
Yoshinaga Takaaki
Kose Yasuhisa
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Publication of BR112014013878A2 publication Critical patent/BR112014013878A2/pt
Publication of BR112014013878A8 publication Critical patent/BR112014013878A8/pt
Publication of BR112014013878B1 publication Critical patent/BR112014013878B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

resumo patente de invenção: "emplastro". a presente invenção refere-se a um emplastro compreendendo uma camada de suporte e uma camada de agente adesiva, em que a camada de agente adesiva contém diclofenaco ou um sal farmaceuticamente aceitável do mesmo, glicerina, butileno glicol, e mono-oleato de poli(etileno) glicol, e uma relação de massa entre o butileno glicol e o mono-oleato de poli(etileno) glicol (massa de butileno glicol:massa de mono-oleato de poli(etileno) glicol) é 1:1 a 4:1.
BR112014013878-8A 2011-12-07 2012-12-06 Emplastro compreendendo uma camada de agente adesiva compreendendo diclofenaco ou um sal farmaceuticamente aceitável do mesmo BR112014013878B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011-267470 2011-12-07
JP2011267470 2011-12-07
PCT/JP2012/081657 WO2013084995A1 (ja) 2011-12-07 2012-12-06 貼付剤

Publications (3)

Publication Number Publication Date
BR112014013878A2 BR112014013878A2 (pt) 2017-06-13
BR112014013878A8 true BR112014013878A8 (pt) 2017-06-13
BR112014013878B1 BR112014013878B1 (pt) 2021-12-07

Family

ID=48574350

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014013878-8A BR112014013878B1 (pt) 2011-12-07 2012-12-06 Emplastro compreendendo uma camada de agente adesiva compreendendo diclofenaco ou um sal farmaceuticamente aceitável do mesmo

Country Status (9)

Country Link
US (1) US20140322300A1 (pt)
EP (1) EP2789335B1 (pt)
JP (1) JP5576573B2 (pt)
KR (1) KR101890011B1 (pt)
CN (1) CN103974700B (pt)
BR (1) BR112014013878B1 (pt)
ES (1) ES2620878T3 (pt)
TW (1) TWI572373B (pt)
WO (1) WO2013084995A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6469136B2 (ja) * 2014-12-22 2019-02-13 久光製薬株式会社 パップ剤
WO2017014306A1 (ja) * 2015-07-22 2017-01-26 積水化学工業株式会社 製剤
EP3645602B1 (en) * 2017-11-06 2023-06-07 BestHealth4U, Lda Adhesion materials and methods of manufacture
WO2019167728A1 (ja) * 2018-02-27 2019-09-06 久光製薬株式会社 ジクロフェナク含有乳化ゲル組成物
JP2020066592A (ja) * 2018-10-24 2020-04-30 帝國製薬株式会社 水性貼付剤
CN113423392A (zh) * 2019-02-18 2021-09-21 久光制药株式会社 冷却片

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6160608A (ja) 1984-08-30 1986-03-28 Taisho Pharmaceut Co Ltd ジクロフェナック湿布剤
JPS6391318A (ja) 1986-10-03 1988-04-22 Teikoku Seiyaku Kk ジクロフエナクナトリウム含有貼付剤
JPH07121860B2 (ja) 1989-09-22 1995-12-25 エスエス製薬株式会社 外用薬剤組成物
JPH03109327A (ja) * 1989-09-22 1991-05-09 Maeda Yakuhin Kogyo Kk 消炎鎮痛外用貼付剤
WO1993000873A1 (en) * 1991-07-03 1993-01-21 Sano Corporation Composition and method for transdermal delivery of diclofenac
JPH0656660A (ja) * 1992-07-31 1994-03-01 Nippon Saafuakutanto Kogyo Kk ジクロフェナクナトリウム含有貼付剤
US6290991B1 (en) * 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
JPH08319213A (ja) * 1995-05-23 1996-12-03 Pacific Corp 美容及び医療用の粘着性パックシート
JP4275751B2 (ja) 1996-12-27 2009-06-10 久光製薬株式会社 外用組成物
TW450810B (en) * 1997-02-20 2001-08-21 Fujisawa Pharmaceutical Co Macrolides antibiotic pharmaceutical composition for preventing and treating skin diseases
JP2001064161A (ja) * 1999-08-30 2001-03-13 Lion Corp 貼付剤
KR20020012978A (ko) * 2000-08-10 2002-02-20 이영길 진통소염 효과를 갖는 디클로페낙염을 함유 카타플라스마제
JP2002193793A (ja) 2000-12-26 2002-07-10 Teikoku Seiyaku Co Ltd 非ステロイド系消炎鎮痛貼付剤
US7473432B2 (en) * 2002-10-11 2009-01-06 Idea Ag NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
KR101312814B1 (ko) * 2005-02-03 2013-09-27 오노 야꾸힝 고교 가부시키가이샤 경피 흡수형 제제
PL1872796T3 (pl) * 2005-02-25 2012-01-31 Hisamitsu Pharmaceutical Co Preparat przezskórny do stosowania zewnętrznego zawierający niesteroidowy lek przeciwzapalny/przeciwbólowy
WO2008001200A2 (en) * 2006-06-29 2008-01-03 Antares Pharma Ipl Ag Transdermal composition having enhanced color stability
JP5020554B2 (ja) * 2006-06-29 2012-09-05 ライオン株式会社 非水系粘着剤組成物とこれを用いた貼付剤
JP4526598B2 (ja) * 2007-08-29 2010-08-18 祐徳薬品工業株式会社 乳化型外用剤およびその製造方法
JPWO2010103845A1 (ja) * 2009-03-11 2012-09-13 興和株式会社 鎮痛・抗炎症剤含有外用剤

Also Published As

Publication number Publication date
EP2789335B1 (en) 2017-02-15
US20140322300A1 (en) 2014-10-30
CN103974700B (zh) 2015-12-09
EP2789335A4 (en) 2015-07-22
BR112014013878A2 (pt) 2017-06-13
BR112014013878B1 (pt) 2021-12-07
EP2789335A1 (en) 2014-10-15
KR101890011B1 (ko) 2018-08-20
CN103974700A (zh) 2014-08-06
ES2620878T3 (es) 2017-06-30
KR20140099318A (ko) 2014-08-11
TW201328730A (zh) 2013-07-16
JP5576573B2 (ja) 2014-08-20
TWI572373B (zh) 2017-03-01
WO2013084995A1 (ja) 2013-06-13
JPWO2013084995A1 (ja) 2015-04-27

Similar Documents

Publication Publication Date Title
BR112014013878A8 (pt) emplastro
BR112014010291A2 (pt) composições de lipossoma combinacionais para terapia de câncer
BR112013030599A2 (pt) núcleo absorvente para artigos absorventes descartáveis
BR112015012197A2 (pt) terapia de combinação
CL2013001947A1 (es) Composicion farmaceutica que comprende pioglitazona; uso de pioglitazona para tratar alzheimer; composicion que comprende pioglitazona.
CR20140388A (es) Compuestos terapeuticamente activos y sus métodos de uso
BR112015022197A8 (pt) uso de um composto para fabricação de um medicamento ou composição farmacêutica para o tratamento de cataplexia
PH12016502355B1 (en) Pharmaceutical composition
ECSP12012318A (es) Inhibidores de pirazolil quinazolina cinasa
BR112013029271A2 (pt) cicatrização de tecido
CR20120596A (es) 5-fluoro-1h-pirazolopiridinas sustituidas y su uso
WO2015054619A3 (en) Use of a pcsk9 inhibitor to treat hyperlipidemia
CL2015002733A1 (es) Composición farmacéutica de clorhidrato de s-cetamina.
UA113165C2 (xx) Застосування комбінації баклофену і акампросату для лікування неврологічних захворювань та композиція, яка містить баклофен і акампросат
CL2012002317A1 (es) Compuestos derivados de tienopirimidinas, inhibitores de quinasas mnk1/mnk2; composicion farmaceutica; y su uso para elt ratamiento o profilaxis de enfermedades metabolicas, tales como diabetes, daño renal, cancer, enfermedades inflamatorias, entre otras.
BR112012016853A2 (pt) "composições farmacêuticas para administração oral de peptídeos de insulina".
ECSP13012658A (es) Composiciones y métodos para el tratamiento de la mielofibrosis
GT201400012A (es) Compuesto inhibidor de la señalizacion de la trayectoria notch
BR112014001118A2 (pt) combinação tópica para aplicação oftálmica e uso de bimatoprost e brimonidina
BR112013016862A2 (pt) combinação de um agonista de opioide e um antagonista de opioide no tratamento de doença de parkinson
BR112015008297A2 (pt) antagonistas de mglu2/3 para o tratamento de distúrbios autistas
CR20140005A (es) Una nueva composición terapéutica que contiene apomorfina como principio activo
EA201400628A1 (ru) Трансдермальная терапевтическая система для введения фентанила или его аналога
BR112012022243A8 (pt) Uso de um inibidor de autofagia baseado em tioxantona e de um composto indutor de autofagia para terapia de câncer, composição farmacêutica e kit farmacêutico
BR112014020113A8 (pt) Composições farmacêuticas e método para diminuir a frequência de micção

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/12/2012, OBSERVADAS AS CONDICOES LEGAIS.